TrademarkOpen
Search / United States / 98294780

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Trademark

OPAL

Allowed — statement of use stage
Third Extension - Granted
Used for: Pharmaceutical preparations, namely, liquid embolic agents; syringes sold filled with liquid embolic agents…
Show more

Pharmaceutical preparations, namely, liquid embolic agents; syringes sold filled with liquid embolic agents; Pharmaceutical preparations for human use for the treatment of endovascular diseases, anatomical abnormalities, tumor embolization, and hemorrhage injuries

Class 5 – Pharmaceuticals & supplements

Status timeline

  1. 1 Dec 2023
    Application filed
    New Application Entered
  2. 29 Jun 2024
    Assigned to an examining attorney
    Assigned To Examiner
  3. 5 Jul 2024
    Office action issued
    Non-Final Action Written
  4. 3 Oct 2024
    Response to office action filed
    Teas Response To Office Action Received
  5. 4 Oct 2024
    Approved for publication
    Approved For Pub - Principal Register
  6. 19 Nov 2024
    Published for opposition
    Published For Opposition
  7. 31 Dec 2024
    Notice of allowance issued — statement of use required
    Noa Mailed - Sou Required From Applicant
  8. 30 Jun 2025
    Statement-of-use extension 1 granted
    Sou Extension 1 Granted
  9. 30 Dec 2025
    Statement-of-use extension 2 granted
    Sou Extension 2 Granted
  10. 29 Jun 2026
    Statement-of-use extension 3 granted
    Sou Extension 3 Granted
All 30 events
2026-06-30Notice Of Approval Of Extension Request E-Mailed
2026-06-29Sou Teas Extension Received
2026-06-29Sou Extension 3 Filed
2026-06-29Sou Extension 3 Granted
2025-12-30Sou Extension 2 Granted
2025-12-30Notice Of Approval Of Extension Request E-Mailed
2025-12-29Sou Teas Extension Received
2025-12-29Sou Extension 2 Filed
2025-06-30Sou Teas Extension Received
2025-06-30Sou Extension 1 Filed
2025-06-30Sou Extension 1 Granted
2025-06-30Notice Of Approval Of Extension Request E-Mailed
2024-12-31Noa Mailed - Sou Required From Applicant
2024-11-19Published For Opposition
2024-11-19Official Gazette Publication Confirmation E-Mailed
2024-11-13Notification Of Notice Of Publication E-Mailed
2024-10-04Approved For Pub - Principal Register
2024-10-03Teas Response To Office Action Received
2024-10-03Correspondence Received In Law Office
2024-10-03Teas/Email Correspondence Entered
2024-07-05Non-Final Action Written
2024-07-05Non-Final Action E-Mailed
2024-07-05Notification Of Non-Final Action E-Mailed
2024-06-29Assigned To Examiner
2024-06-12Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
2024-06-12Attorney/Dom.rep.revoked And/Or Appointed
2024-06-12Teas Change Of Correspondence Received
2024-06-12Teas Withdrawal Of Attorney Received-Firm Retains
2024-02-25New Application Office Supplied Data Entered
2023-12-01New Application Entered

Goods & services by class

Class 5 Pharmaceuticals & supplements

Pharmaceutical preparations, namely, liquid embolic agents; syringes sold filled with liquid embolic agents; Pharmaceutical preparations for human use for the treatment of endovascular diseases, anatomical abnormalities, tumor embolization, and hemorrhage injuries

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 30 Jun 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.